Yet, based on the available studies, semaglutide appears to be more effective in improving glycemic control, as measured by the reduction in the levels of glycated hemoglobin (HbA1c): According to data from the SUSTAIN-FORTE trial, there was a -2.2% reduction in baseline HbA1c with 2mg/weekly semaglutide and 1.9% reduction with 1mg/weekly semaglutide after 40 weeks [21] The AWARD-11 trial revealed a -1.77% reduction in baseline HbA1c with 4.5mg/weekly dulaglutide after 36 weeks [18]
Semaglutide weight loss dosage chart Key highlights Semaglutide is FDA-approved prescription medication for weight loss for obese (BMI 30 or higher) and overweight patients (BMI 27 or higher) The typical starting dose of semaglutide injection is 0.25 mg once per week, which can be increased up to 2.4 mg once per week, depending on the patient's tolerance and glycemic control
Who decides which one is right for you The honest takeaway isnt that one is good and the other bad. Theyre different tools for different situations: phentermine, a stimulant appetite suppressant meant for a few-week push
Published case reports describe three patients on semaglutide presenting with "minimal frothy saliva" and significant oral discomfort, confirming this is a recognized clinical finding rather than an isolated complaint
Ehrsam, S